Literature DB >> 1606190

Postural imbalance: an early sign in HIV-1 infected patients.

C Trenkwalder1, A Straube, W Paulus, S Krafczyk, E Schielke, K M Einhäupl.   

Abstract

We have recorded postural performance in 50 HIV-infected patients in different stages of the disease (Walter Reed (WR) stages I-VI) by means of a force measuring platform. The results were compared with 50 age-matched controls. A significant instability was particularly evident when standing on an unstable foot support. In patients standing with "eyes closed", postural sway was significantly higher in every patient group (WR I-II: P less than 0.02, WR III-V: P less than 0.001, WR VI: P less than 0.001). Patients in stage WR I-II showed no relevant neurological abnormalities. In agreement with other neurophysiological data in the literature we suggest that postural imbalance could be an early sign of central nervous system penetration of HIV. No correlation with electromyographic or cerebrospinal fluid findings could be found.

Entities:  

Mesh:

Year:  1992        PMID: 1606190     DOI: 10.1007/bf02195975

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  26 in total

1.  Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection.

Authors:  R S Janssen; A J Saykin; L Cannon; J Campbell; P F Pinsky; N A Hessol; P M O'Malley; A R Lifson; L S Doll; G W Rutherford
Journal:  Ann Neurol       Date:  1989-11       Impact factor: 10.422

2.  Early neurologic abnormalities in HIV infection.

Authors:  M R Nuwer; E N Miller; B R Visscher; P Satz
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

3.  Differential effects of retinal target displacement, changing size and changing disparity in the control of anterior/posterior and lateral body sway.

Authors:  W Paulus; A Straube; S Krafczyk; T Brandt
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  The Walter Reed staging classification for HTLV-III/LAV infection.

Authors:  R R Redfield; D C Wright; E C Tramont
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

5.  Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

Authors:  S Gartner; P Markovits; D M Markovitz; R F Betts; M Popovic
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

6.  Reduced cerebral blood flow in early stages of human immunodeficiency virus infection.

Authors:  E Schielke; K Tatsch; H W Pfister; C Trenkwalder; G Leinsinger; C M Kirsch; A Matuschke; K M Einhäupl
Journal:  Arch Neurol       Date:  1990-12

7.  Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV.

Authors:  R Kaiser; R Dörries; W Lüer; S Poser; H D Pohle; K Felgenhauer; V ter Meulen
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

8.  Long latency event-related potentials in patients infected with human immunodeficiency virus.

Authors:  D S Goodin; M J Aminoff; D N Chernoff; H Hollander
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

9.  The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection.

Authors:  B A Navia; R W Price
Journal:  Arch Neurol       Date:  1987-01

10.  Early penetration of the blood-brain-barrier by HIV.

Authors:  L Resnick; J R Berger; P Shapshak; W W Tourtellotte
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

View more
  8 in total

1.  Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia.

Authors:  Edith V Sullivan; Margaret J Rosenbloom; Torsten Rohlfing; Carol A Kemper; Stanley Deresinski; Adolf Pfefferbaum
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

2.  Sensorimotor dysfunction in HIV/AIDS: effects of antiretroviral treatment and comorbid psychiatric disorders.

Authors:  Lance O Bauer; Natalie A Ceballos; John D Shanley; Leslie I Wolfson
Journal:  AIDS       Date:  2005-03-25       Impact factor: 4.177

Review 3.  Physical function, grip strength and frailty in people living with HIV in sub-Saharan Africa: systematic review.

Authors:  Charlotte Bernard; François Dabis; Nathalie de Rekeneire
Journal:  Trop Med Int Health       Date:  2017-03-08       Impact factor: 2.622

4.  Gait and Balance Biomechanics in Older Adults With and Without Human Immunodeficiency Virus.

Authors:  Alice S Ryan; Anindo Roy; Krisann K Oursler
Journal:  AIDS Res Hum Retroviruses       Date:  2019 Nov/Dec       Impact factor: 2.205

5.  Variations in plantar pressure and balance in HIV-infected children in antiretroviral therapy.

Authors:  Lucieny da Silva Pontes; Bianca Callegari; Lizandra Magno; Anderson Moraes; Bruno Giovanni Silva; Kaio Manso; Brenison Barros; Ana Paula Araújo; Maria Clara Silva; George Alberto Dias; Beatriz Helena Vasconcelos; Anselmo Costa E Silva; Rosana Maria Libonati; Givago Silva Souza
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

6.  Investigation of physical and functional impairments experienced by people with active tuberculosis infection: A feasibility pilot study.

Authors:  Heleen van Aswegen; Ronel Roos; Melanie McCree; Samantha Quinn; Mervyn Mer
Journal:  Afr J Disabil       Date:  2019-08-13

Review 7.  Objective impairments of gait and balance in adults living with HIV-1 infection: a systematic review and meta-analysis of observational studies.

Authors:  Karina Berner; Linzette Morris; Jochen Baumeister; Quinette Louw
Journal:  BMC Musculoskelet Disord       Date:  2017-08-01       Impact factor: 2.362

8.  Fall History and Associated Factors Among Adults Living With HIV-1 in the Cape Winelands, South Africa: An Exploratory Investigation.

Authors:  Karina Berner; Hans Strijdom; M Faadiel Essop; Ingrid Webster; Linzette Morris; Quinette Louw
Journal:  Open Forum Infect Dis       Date:  2019-10-09       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.